Loxapine 50 MG Oral Capsule
INDICATIONS AND USAGE Loxapine Capsules, USP are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.
lannett company, inc.
CAPSULE GREEN Lannett 1397
Related Pills
Loxapine 25 MG Oral Capsule
lannett company, inc.
Loxapine 5 MG Oral Capsule
lannett company, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
LOXAPINE capsules, USP are available in the following strengths:
LOXAPINE Succinate, USP 6.8 mg equivalent to 5 mg
LOXAPINE, opaque, with a dark green body and cap, imprinted with logo "LANNETT" on the cap and "1394" on the body are supplied as follows: NDC 0527-1394-01 –Bottle of 100s NDC 0527-1394-10 –Bottle of 1000s
LOXAPINE Succinate, USP 13.6 mg equivalent to 10 mg
LOXAPINE, yellow opaque body and dark green opaque cap, imprinted with logo "LANNETT" on the cap and "1395" on the body are supplied as follows: NDC 0527-1395-01 –Bottle of 100s NDC 0527-1395-10 –Bottle of 1000s
LOXAPINE Succinate, USP 34.0 mg equivalent to 25 mg
LOXAPINE, light green opaque body and dark green opaque cap, imprinted with logo "LANNETT" on the cap and "1396" on the body are supplied as follows: NDC 0527-1396-01 –Bottle of 100s NDC 0527-1396-10 –Bottle of 1000s
LOXAPINE Succinate, USP 68.1 mg equivalent to 50 mg
LOXAPINE, light blue opaque body and dark green opaque cap, imprinted with logo "LANNETT" on the cap and "1397" on the body are supplied as follows: NDC 0527-1397-01 –Bottle of 100s NDC 0527-1397-10 –Bottle of 1000s Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] Dispense in a tight, child-resistant container. Distributed by: Lannett Company, Inc. Philadelphia, PA 19136 CIB70541F Rev. 11/24
More pills like CAPSULE Lannett 1397